WallStreetZenWallStreetZen

NASDAQ: ENTA
Enanta Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for ENTA

Based on 5 analysts offering 12 month price targets for Enanta Pharmaceuticals Inc.
Min Forecast
$15.00+42.99%
Avg Forecast
$29.60+182.17%
Max Forecast
$48.00+357.58%

Should I buy or sell ENTA stock?

Based on 5 analysts offering ratings for Enanta Pharmaceuticals Inc.
Hold
Strong Buy
0 analysts 0%
Buy
2 analysts 40%
Hold
3 analysts 60%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ENTA stock forecasts and price targets.

ENTA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
RBC Capital
Top 9%
92
HoldMaintains$15.00+42.99%2023-10-02
HC Wainwright & Co.
Bottom 2%
2
BuyReiterates$48.00+357.58%2023-09-19
Oppenheimer
Top 6%
95
HoldMaintains$25.00+138.32%2023-08-09
JMP Securities
Bottom 3%
3
BuyMaintains$42.00+300.38%2023-08-08
Jefferies
Bottom 14%
14
HoldDowngrades$18.00+71.59%2023-08-08

1 of 1

Forecast return on equity

Is ENTA forecast to generate an efficient return?
Company
N/A
Industry
0.66%
Market
28.71%

Forecast return on assets

Is ENTA forecast to generate an efficient return on assets?
Company
N/A
Industry
-0.05%

ENTA revenue growth forecast

How is ENTA forecast to perform vs Biotechnology companies and vs the US market?
Company
114.29%
Industry
34.31%
Market
8.24%
ENTA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ENTA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ENTA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ENTA$10.49$29.60+182.17%Hold
QSI$1.57$2.00+27.39%Hold
GLUE$4.52$11.00+143.36%Hold
AKBA$1.15$3.88+236.96%Strong Buy
AEON$5.83$18.00+208.75%Buy
View Top Biotech Stocks

Enanta Pharmaceuticals Stock Forecast FAQ

Is Enanta Pharmaceuticals Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 5 Wall Street analysts covering (NASDAQ: ENTA) stock is to Hold ENTA stock.

Out of 5 analysts, 0 (0%) are recommending ENTA as a Strong Buy, 2 (40%) are recommending ENTA as a Buy, 3 (60%) are recommending ENTA as a Hold, 0 (0%) are recommending ENTA as a Sell, and 0 (0%) are recommending ENTA as a Strong Sell.

If you're new to stock investing, here's how to buy Enanta Pharmaceuticals stock.

What is ENTA's forecast return on equity (ROE) for 2024-2026?

(NASDAQ: ENTA) forecast ROE is N/A, which is considered weak.

What is ENTA's Price Target?

According to 5 Wall Street analysts that have issued a 1 year ENTA price target, the average ENTA price target is $29.60, with the highest ENTA stock price forecast at $48.00 and the lowest ENTA stock price forecast at $15.00.

On average, Wall Street analysts predict that Enanta Pharmaceuticals's share price could reach $29.60 by Oct 2, 2024. The average Enanta Pharmaceuticals stock price prediction forecasts a potential upside of 182.17% from the current ENTA share price of $10.49.

What is ENTA's forecast return on assets (ROA) for 2024-2026?

(NASDAQ: ENTA) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of -0.05%.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.